American International Group’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

American International Group’s Portfolio LOGC Stock Details LOGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,559	Closed	-$70	–	3348
2021 Q1	$70	Buy	9,559 +26	+0.3%	+$214	﹤0.01%	2880
2020 Q4	$73	Buy	9,533 +2,239	+31%	+$15K	﹤0.01%	2813
2020 Q3	$66K	Sell	7,294 -64	-0.9%	-$486	﹤0.01%	2758
2020 Q2	$62K	Buy	7,358 +2,442	+50%	+$16.1K	﹤0.01%	2801
2020 Q1	$24K	Sell	4,916 -285	-5%	-$2.22K	﹤0.01%	2895
2019 Q4	$37K	Buy	5,201 +16	+0.3%	+$145	﹤0.01%	2948
2019 Q3	$56K	Sell	5,185 -131	-2%	-$1.4K	﹤0.01%	2873
2019 Q2	$69K	Buy	5,316 +319	+6%	+$4.24K	﹤0.01%	2858
2019 Q1	$49K	Sell	4,997 -353	-7%	-$3.29K	﹤0.01%	2885
2018 Q4	$56K	Buy	+5,350	New	+$64.6K	﹤0.01%	2845

Other funds holding LOGC

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

American International Group's LOGC Position: Q2 2021 in Review

American International Group sold out of LogicBio Therapeutics, Inc. Common Stock (LOGC) in Q2 2021, closing a stake of 9,559 shares — an estimated $70 sold.

American International Group first reported a position in LOGC in Q4 2018 and held it in 10 quarters. The position peaked at $69K in Q2 2019. 63 funds tracked by Wall St. Rank hold LOGC as of Q2 2021.

American International Group reported no remaining LogicBio Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
American International Group sold 9,559 LogicBio Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $70.
American International Group first reported a position in LogicBio Therapeutics, Inc. Common Stock in Q4 2018 and held it in 10 quarters.
American International Group's LogicBio Therapeutics, Inc. Common Stock position peaked at $69K in Q2 2019.
63 funds tracked by Wall St. Rank held LogicBio Therapeutics, Inc. Common Stock as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.